1. Home
  2. CVRX vs FOF Comparison

CVRX vs FOF Comparison

Compare CVRX & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • FOF
  • Stock Information
  • Founded
  • CVRX 2000
  • FOF 2006
  • Country
  • CVRX United States
  • FOF United States
  • Employees
  • CVRX N/A
  • FOF N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FOF Investment Managers
  • Sector
  • CVRX Health Care
  • FOF Finance
  • Exchange
  • CVRX Nasdaq
  • FOF Nasdaq
  • Market Cap
  • CVRX 419.8M
  • FOF 341.7M
  • IPO Year
  • CVRX 2021
  • FOF N/A
  • Fundamental
  • Price
  • CVRX $12.23
  • FOF $12.08
  • Analyst Decision
  • CVRX Strong Buy
  • FOF
  • Analyst Count
  • CVRX 7
  • FOF 0
  • Target Price
  • CVRX $17.83
  • FOF N/A
  • AVG Volume (30 Days)
  • CVRX 206.7K
  • FOF 58.7K
  • Earning Date
  • CVRX 04-29-2025
  • FOF 01-01-0001
  • Dividend Yield
  • CVRX N/A
  • FOF 9.07%
  • EPS Growth
  • CVRX N/A
  • FOF N/A
  • EPS
  • CVRX N/A
  • FOF N/A
  • Revenue
  • CVRX $51,292,000.00
  • FOF N/A
  • Revenue This Year
  • CVRX $27.21
  • FOF N/A
  • Revenue Next Year
  • CVRX $25.87
  • FOF N/A
  • P/E Ratio
  • CVRX N/A
  • FOF N/A
  • Revenue Growth
  • CVRX 30.53
  • FOF N/A
  • 52 Week Low
  • CVRX $6.40
  • FOF $9.59
  • 52 Week High
  • CVRX $19.24
  • FOF $11.75
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 44.32
  • FOF 43.64
  • Support Level
  • CVRX $11.80
  • FOF $12.12
  • Resistance Level
  • CVRX $12.94
  • FOF $12.29
  • Average True Range (ATR)
  • CVRX 0.56
  • FOF 0.15
  • MACD
  • CVRX 0.17
  • FOF 0.03
  • Stochastic Oscillator
  • CVRX 53.94
  • FOF 55.32

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

Share on Social Networks: